A Yale secret-shopper study tried 49 direct-to-consumer GLP-1 sites. 45 wrote a prescription, some in five minutes. What the questionnaire mills skip, and how to spot real care.
The GLP-1 muscle loss panic scared me into training at 50. It turned out overblown, but the habit stuck. What the evidence actually says about muscle, and why you train after 50.
A research platform lets anyone turn health records into a publishable-looking study in an afternoon. Here is how that floods the GLP-1 and cancer literature, and how I read these studies now.
Retatrutide isn’t FDA approved, but it has a street name, a grey market with customer service, and Wall Street’s full attention. What the strongest weight-loss drug ever tested means, and why I’m not taking it.
A new study found people on GLP-1 drugs took fewer steps after starting. I lost the weight and moving got easier, so I went looking for why most people slow down.
The food noise went quiet. Then I had to rebuild the rest.
Wholesale whey protein is up fivefold in three years and suppliers are sold out. GLP-1 users chasing protein targets repriced the market, and the same drug is shrinking cheese demand that whey depends on.
Updated September 17, 2026 with the FDA’s September approval of Isembyld (apitegromab), the trial numbers behind it, the fracture and fertility safety data that came with the label, and where the drug can actually be prescribed. The tabloids are calling it the cure for “Ozempic butt.” But it saved lean mass on a scan, not
You order a prescription online and it arrives in days. Some of it is real care. Some is a sales funnel in a white coat. Here is how to tell the difference.
I take tirzepatide. So when the headline came through this week that GLP-1 drugs might slow the spread of cancer, it intrigued me more than most drug news. This is the medication in my own refrigerator. I went and read the actual study instead of the headline, and the short version is that the signal
